The company’s shares rose as investors breathed a sigh of relief on strong sales growth and guidance, despite ongoing ...

With the announcement that the great David Lynch died on January 16, the world hasn’t just lost one of its greatest filmmakers: It’s lost one of its greatest artists, period. The work of a ...

Finally, some good news for Novo Nordisk (NYSE: NVO) shareholders! Twice in the past two months, the Danish manufacturer of GLP-1 drugs for weight loss and diabetes treatment has reported clinical ...

Novo Nordisk shares rose sharply Friday after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their bodyweight in a clinical trial. Shares were 10 ...

Novo Nordisk is facing serious pressure from a powerful adversary. It still has plenty of leeway to penetrate its target market, for now. Investors should keep a close eye on this company.

With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo Nordisk A/S (NYSE: NVO). A Scandinavian economic behemoth ...

David Lynch, who died this week at 78, was one of those artists. Just to say that name, David Lynch (so ironic in its simplicity), is to conjure not merely a roster of immortal movies but a higher ...

After news broke Thursday of the death of filmmaker David Lynch at age 78, tributes from his former collaborators began coming out as well, including actors Kyle MacLachlan and Nicolas Cage ...

David Lynch, the groundbreaking director of films and shows including "Twin Peaks" and "Blue Velvet," has died at the age of 78, his family announced Thursday. "It is with deep regret that we, his ...

It would be impossible to overstate the late David Lynch‘s impact on The A.V. Club, past and present. To pay tribute, we’re touching up some archival posts and lining up additional features ...